Get vaccinated today to protect yourself and others around you
Each autumn, Britain faces the quiet arithmetic of preventable illness — who will be protected, and who will not. This year, the NHS has launched its flu vaccination programme with unusual urgency, driven by rising respiratory infections and the shadow of a difficult winter ahead. The programme extends free jabs to millions across six priority groups, from the elderly to frontline carers, with only one firm boundary: those who have suffered severe allergic reactions to the vaccine or its ingredients should not receive it. In a season already marked by converging illness, the act of vaccination becomes less a personal choice than a communal one.
- Influenza cases are climbing before winter has even arrived, and COVID-19 infections are rising alongside a 50 percent surge in rhinovirus — the NHS is bracing for a collision of respiratory illnesses.
- The health service has structured its rollout in waves, with children and pregnant women eligible from September and six adult priority groups — including the over-65s, care home residents, and healthcare workers — gaining access from October 1.
- The only people who must not receive the vaccine are those with a history of anaphylaxis to a previous dose or its ingredients, though egg allergy sufferers can still be accommodated with egg-free formulations.
- To close the gap between eligibility and uptake, the NHS is deploying mobile vaccination buses, neighbourhood drop-in sessions, and — for the first time — pharmacy-based jabs for toddlers aged two and three.
- The underlying message from NHS leadership is collective: getting vaccinated shields not just the individual but the vulnerable people around them, and a jab now may mean one fewer hospitalisation when winter peaks.
As autumn deepens across Britain, the NHS has launched its flu vaccination programme with a sense of particular urgency. Influenza cases are already rising. COVID-19 infections have climbed steadily since the XFG variant emerged in May. Rhinovirus has surged 50 percent, partly driven by children returning to school. Health officials are preparing for a winter in which multiple respiratory illnesses converge — straining hospitals and overwhelming primary care.
The rollout began in stages. From September 1, younger children, pregnant women, and those aged six months to under 18 with clinical risk factors became eligible. From October 1, six further groups gained access to free jabs: adults 65 and over, those aged 18 to 65 with long-term conditions, care home residents, carers of elderly or disabled people, those living with immunocompromised household members, and frontline health and social care workers.
The eligibility is deliberately wide. Flu can be fatal for the elderly, the chronically ill, and the immunocompromised — and those around them can carry the virus home without knowing it. The NHS is explicit about the only group who should not be vaccinated: anyone with a history of anaphylaxis to a previous dose or to any ingredient in the vaccine. Some formulations contain egg protein, so people with egg allergies should inform their vaccinator, who can offer an egg-free alternative or take appropriate precautions.
To reach as many people as possible, the NHS is deploying mobile vaccination buses, running neighbourhood drop-in sessions, and — in a notable expansion — allowing community pharmacies to vaccinate two- and three-year-olds for the first time. The strategy is built on a simple premise: a vaccine given now is a hospitalisation avoided later. Whether the effort proves sufficient will depend on the winter ahead.
The NHS has opened its flu vaccination programme across the country, and for most people in Britain, the decision is straightforward: get the shot. But for a small group, the answer is no.
As autumn settles in and winter looms, the health service is preparing for what it expects will be a difficult season. Cases of influenza are already climbing. COVID-19 infections have been rising steadily for weeks, spurred by the emergence of the XFG variant in May. Rhinovirus, which causes the common cold, has surged 50 percent—a jump officials attribute partly to children returning to school after summer break. The NHS is bracing for a convergence of respiratory illnesses that could strain hospitals and overwhelm primary care.
The vaccination push began in stages. Starting September 1, younger children became eligible: those in primary and secondary school, all children from six months to under 18 with clinical risk factors, pregnant women, and two- and three-year-olds. From October 1, six additional priority groups gained access to free flu jabs. These include adults aged 65 and over, people between 18 and 65 with long-term health conditions, residents of care homes, primary carers of elderly or disabled individuals (including those receiving carer's allowance), people living with immunocompromised household members, and frontline health and social care workers.
The eligibility criteria are broad by design. The flu vaccine protects against a virus that can prove deadly to vulnerable populations—the elderly, the chronically ill, those whose immune systems are compromised. The NHS delivers it free to those most at risk, and to those around them who might carry infection into their homes.
But there are exceptions. The NHS is explicit about who should not receive the vaccine: anyone who has experienced anaphylaxis—a severe, life-threatening allergic reaction—to a previous dose, or to any ingredient within it. This is the only absolute contraindication. Some flu vaccines used in the UK contain egg protein, so people with egg allergies need to inform the person administering the jab. With that information, healthcare providers can either use an egg-free formulation or take appropriate precautions.
Beyond that narrow group, nearly everyone eligible should get vaccinated. The message from NHS leadership is unambiguous: the vaccine protects not only the person receiving it but those around them. A dose now could mean avoiding hospitalization when winter peaks.
To reach people, the NHS is deploying new tactics. Mobile vaccination buses are traveling to communities, bringing the jab closer to home. Family drop-in sessions are running in neighborhoods. And for the first time, some community pharmacies are offering flu vaccines to two- and three-year-olds—a significant expansion of access for young children. The strategy reflects both the scale of expected illness and the determination to make vaccination as frictionless as possible. The winter ahead will test whether these efforts are enough.
Citas Notables
Get vaccinated today to protect yourself and others around you, it might keep you out of hospital this winter— NHS England National Director for Primary Care and Community Services
La Conversación del Hearth Otra perspectiva de la historia
Why does the NHS need to spell out who shouldn't get the vaccine? Isn't that obvious?
You'd think so, but vaccine hesitancy often stems from confusion or fear. People hear "vaccine" and their minds flood with worst-case scenarios. Being explicit—saying clearly that anaphylaxis is the only real barrier—removes that fog. It's permission, in a way.
And the egg protein thing—that seems like a detail that could get lost.
It does get lost. That's why they're asking people to tell their vaccinator. It's a safety net. Most people with egg allergies can still get vaccinated; they just need the right formulation or a bit of extra care. But if no one speaks up, someone could have a bad reaction that was entirely preventable.
The NHS is using pharmacies for two- and three-year-olds for the first time. Why now?
Because they're expecting a rough winter and they need to vaccinate as many people as possible, as quickly as possible. Pharmacies are everywhere. They're accessible. It's a practical response to a forecast of higher illness.
Do you think people will actually use the mobile buses?
Some will. Others won't. But the buses exist because the NHS knows that access is a real barrier for some people—those without reliable transport, those working irregular hours, those in underserved areas. You remove one barrier, you get more people vaccinated.
What happens if someone shows up with an egg allergy and the pharmacy doesn't have the right vaccine?
That's the risk in expanding access so quickly. The system has to be coordinated. But the alternative—keeping vaccination in clinics only—means fewer people protected. It's a trade-off.